SA PRO
Free Account
MAZEMAZE
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
5 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 6% higher.

Bear Case
$46.00
-4%
Consensus
$51.00
+6%
Bull Case
$60.00
+25%
Price Range5 analysts
Low
Consensus
High
$46.00
$60.00
Current Target
Current Price
$47.97
Upside to Target
$3.03

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 19, 2026BTIG
Maze Therapeutics price target raised to $46 from $37 at BTIG
Target:$46.00
+12.8%from $40.77
Dec 19, 2025Guggenheim
Maze Therapeutics price target raised to $46 from $34 at Guggenheim
Target:$46.00
+9.7%from $41.91
Dec 4, 2025Wells Fargo
Maze Therapeutics initiated with an Overweight at Wells Fargo
Target:$55.00
+32.6%from $41.49
Dec 3, 2025H.C. Wainwright
Maze Therapeutics price target raised to $60 from $50 at H.C. Wainwright
Target:$60.00
+54.9%from $38.74
Nov 13, 2025Raymond James
Maze Therapeutics initiated with a Strong Buy at Raymond James
Target:$48.00
+50.8%from $31.84
Sep 15, 2025Guggenheim
Maze Therapeutics price target raised to $34 from $19 at Guggenheim
Target:$34.00
+46.2%from $23.25
Sep 2, 2025BTIG
Maze Therapeutics initiated with a Buy at BTIG
Target:$30.00
+95.8%from $15.32
Jul 8, 2025Wedbush
Wedbush bullish on Maze Therapeutics, initiates with an Outperform
Target:$17.00
+27.7%from $13.31

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance